WGS Stock Analysis: Buy, Sell, or Hold?
WGS - GeneDx Holdings Corp. Class A Common Stock
$87.07
4.52 (5.47%)
▲
5d:
+11.51%
30d:
+37.37%
90d:
+83.95%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Get Alerted When WGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: WGS is 10.8% above its trading range ($78.55). Market expects -13.0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: WGS is 10.8% above its trading range ($78.55). Market expects -13.0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$56.90
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$35.33
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WGS is currently trading at $87.06, which is considered extended relative to its 30-day fair value range of $62.06 to $78.55. From a valuation perspective, the stock is trading at a discount (Forward PE: 70.6) compared to its historical average (107.3). Remarkably, the market is currently pricing in an annual earnings decline of 13.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, WGS is in a strong uptrend. The price is approaching resistance at $87.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: WGS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, WGS is in a strong uptrend. The price is approaching resistance at $87.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: WGS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$62.06 -
$78.55
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
34.6%
Protect Your Profits
WGS is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.8% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.5%)
- NEUTRAL: Near Wall St target ($90.44)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$62.06 -
$78.55
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$7.94
(9.1%)
Support & Resistance Levels
Support Level
$75.15
Resistance Level
$87.17
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
70.63
Wall Street Target
$90.44
(+9.6%)
Revenue Growth (YoY)
11.4%
Profit Margin
-23.4%
Valuation Discount vs History
-13.0% cheaper
PE vs Historical
70.6 vs 107.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.0%
(market-implied from PE analysis)
1-Year Target
$74.30
(-10%)
2-Year Target
$66.87
(-19%)
3-Year Target
$60.18
(-27%)
3-Yr Target (if PE normalizes)
(PE: 71→107)
$91.43
(+11%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 70.6, Growth: 816.7%)
$278.61
(+238%)
Base:
(SPY PE: 20.1, Growth: 816.7%)
$79.17
(-4%)
Bear:
(PE: 17.1, Growth: 816.7%)
$67.29
(-19%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 70.6 to 107.3
Stabilization Target:
$125.41
(+51.9%)
PE Expansion Potential:
+51.9%
Share & Embed Analysis
Last updated: August 22, 2026 5:31 PM ET
Data refreshes hourly during market hours. Next update: 6:31 PM
Data refreshes hourly during market hours. Next update: 6:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WGS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Katherine Stueland
SELL
46933 shares
2026-03-26
Katherine Stueland
SELL
17179 shares
2026-03-16
Kevin Feeley
SELL
5706 shares
2026-03-16
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 38 SELL |
Advanced WGS Option Strategies
Professional options setups generated by AI based on today's WGS price and gamma walls.
